0001618835-18-000046.txt : 20180703 0001618835-18-000046.hdr.sgml : 20180703 20180703165604 ACCESSION NUMBER: 0001618835-18-000046 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180702 FILED AS OF DATE: 20180703 DATE AS OF CHANGE: 20180703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lynch Thomas G CENTRAL INDEX KEY: 0001360000 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36754 FILM NUMBER: 18938158 MAIL ADDRESS: STREET 1: C/O EVOFEM BIOSCIENCES, INC. STREET 2: 12400 HIGH BLUFF DRIVE, SUITE 600 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Evofem Biosciences, Inc. CENTRAL INDEX KEY: 0001618835 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208527075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12400 HIGH BLUFF DRIVE STREET 2: SUITE 600 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 550-1900 MAIL ADDRESS: STREET 1: 12400 HIGH BLUFF DRIVE STREET 2: SUITE 600 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: Neothetics, Inc. DATE OF NAME CHANGE: 20140905 4 1 wf-form4_153065134806235.xml FORM 4 X0306 4 2018-07-02 0 0001618835 Evofem Biosciences, Inc. EVFM 0001360000 Lynch Thomas G C/O EVOFEM BIOSCIENCES, INC. 12400 HIGH BLUFF DRIVE, SUITE 600 SAN DIEGO CA 92130 1 0 0 0 Common Stock 2018-07-02 4 M 0 75000 0 A 75000 D Restricted Stock Units 2018-07-02 4 A 0 75000 0 A Common Stock 75000.0 75000 D Restricted Stock Units 2018-07-02 4 M 0 75000 0 D Common Stock 75000.0 0 D Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units were granted in consideration for certain consulting services provided to the Issuer in connection with the consulting agreement between Mr. Lynch and the Issuer dated April 1, 2016. The restricted stock units vested in full on July 2, 2018. The restricted stock units were granted subject to a 90-day lock-up agreement pursuant to an Underwriting Agreement, the form of which was filed with a Registration Statement on Form S-1 as filed with the SEC on May 16, 2018. During the 90-day lock-up period commencing from May 22, 2018, the Reporting Person may not sell any vested shares. /s/ Justin J. File, attorney-in-fact 2018-07-03